🔎 Trials Near Me

Akèy › Dyabèt Tip 2 › Florid › Orlando

Etid klinik pou Dyabèt Tip 2 nan Orlando, FL

24 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan ak bò kote Orlando (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Ap rekriteFaz 2
  • Florida Institute For Clinical Research, LLC, Orlando
  • K2 Medical Research - Maitland, Maitland · 6 mi lwen
  • Omega Research Orlando, Altamonte Springs · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Ap rekriteFaz 3
  • Florida Institute for Clinical Research, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Ap rekriteFaz 3
  • Conquest Research, Winter Park · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07754461

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Ap rekriteFaz 3
  • Clinical Site Partners, LLC dba Flourish Research, Winter Park · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Ap rekriteFaz 3
  • Research Site, Ocoee · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Ap rekriteFaz 3
  • AURORA-2 Clinical Site, Winter Park · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

Ap rekriteFaz 2
  • Conquest Research LLC - Winter Park, Winter Park · 5 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 15, 2026 · NCT07340320

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Ap rekriteFaz 2
  • West Orange Endocrinology, Ocoee · 10 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 11, 2026 · NCT07415954

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Ap rekriteFaz 2
  • Central Florida Kidney Specialists Oakwater, Orlando
Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2026 · NCT07271186

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Ap rekriteFaz 2
  • Conquest Research, Winter Park · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07296484

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

Ap rekriteFaz 3
  • Innovus Clinical, Kissimmee · 16 mi lwen
Laj 10 a 18 · Tout sèks · Mizajou Sep 9, 2026 · NCT07282613

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Ap rekriteFaz 3
  • Florida Institute for Clinical Research, Orlando
  • Conquest Research - Winter Park, Winter Park · 5 mi lwen
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684144

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

Ap rekriteFaz 3
  • Research Site, Orlando
  • Research Site, Ocoee · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07662135

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

Ap rekriteEtid obsèvasyon
  • Research Site, Ocoee · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07606066

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Ap rekriteFaz 2
  • Charter Research, Orlando
  • AdventHealth Translational Research Institute, Orlando
Laj 18 a 75 · Tout sèks · Mizajou Aug 17, 2026 · NCT07527650

Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis

Ap rekriteVolontè an sante akeyi
  • AdventHealth Translational Research Institute, Orlando
Laj 25 a 55 · Tout sèks · Mizajou Aug 12, 2026 · NCT06993454

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Ap rekriteFaz 3
  • AdventHealth Orlando, Orlando
Laj 10 a 17 · Tout sèks · Mizajou Aug 7, 2026 · NCT06739122

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

Ap rekriteFaz 3
  • Research Site, Ocoee · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT07664553

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

Ap rekriteFaz 2
  • Flourish Research Orlando, Winter Park · 5 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Jun 15, 2026 · NCT07502508

Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

Ap rekriteFaz 2
  • Florida Institute for Clinical Research LLC, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Mar 18, 2026 · NCT07282743

Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency

Ap rekriteFaz 1Volontè an sante akeyi
  • Orlando Clinical Research Center (OCRC), Orlando
Laj 18 a 80 · Tout sèks · Mizajou Mar 13, 2026 · NCT07385547

The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults

Ap rekriteVolontè an sante akeyi
  • Translational Research Institute for Metabolism and Diabetes, Orlando
Laj 60 a 80 · Tout sèks · Mizajou Mar 13, 2025 · NCT03761446

Etid Dyabèt Tip 2 nan lòt vil

Lòt etid nan Orlando

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.